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Background: Individuals living with sickle cell disease often require aggressive treatment of pain associated with vaso-occlusive
episodes in the emergency department. Frequently, pain relief is poor. The 2014 National Heart, Lung, and Blood Institute
evidence-based guidelines recommended an individualized treatment and monitoring protocol to improve pain management of
vaso-occlusive episodes.
Objective: This study will implement an electronic health record–embedded individualized pain plan with provider and patient
access in the emergency departments of 8 US academic centers to improve pain treatment for adult patients with sickle cell
disease. This study will assess the overall effects of electronic health record–embedded individualized pain plans on improving
patient and provider outcomes associated with pain treatment in the emergency department setting and explore barriers and
facilitators to the implementation process.
Methods: A preimplementation and postimplementation study is being conducted by all 8 sites that are members of the National
Heart, Lung, and Blood Institute–funded Sickle Cell Disease Implementation Consortium. Adults with sickle cell disease aged
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18 to 45 years who had a visit to a participating emergency department for vaso-occlusive episodes within 90 days prior to
enrollment will be eligible for inclusion. Patients will be enrolled in the clinic or remotely. The target analytical sample size of
this study is 160 patient participants (20 per site) who have had an emergency department visit for vaso-occlusive episode treatment
at participating emergency departments during the study period. Each site is expected to enroll approximately 40 participants to
reach the analytical sample size. The electronic health record–embedded individualized pain plans will be written by the patient’s
sickle cell disease provider, and sites will work with the local informatics team to identify the best method to build the electronic
health record–embedded individualized pain plan with patient and provider access. Each site will adopt required patient and
provider implementation strategies and can choose to adopt optional strategies to improve the uptake and sustainability of the
intervention. The study is informed by the Technology Acceptance Model 2 and the Reach, Effectiveness, Adoption,
Implementation, and Maintenance framework. Provider and patient baseline survey, follow-up survey within 96 hours of an
emergency department vaso-occlusive episode visit, and selected qualitative interviews within 2 weeks of an emergency department
visit will be performed to assess the primary outcome, patient-perceived quality of emergency department pain treatment, and
additional implementation and intervention outcomes. Electronic health record data will be used to analyze individualized pain
plan adherence and additional secondary outcomes, such as hospital admission and readmission rates.
Results: The study is currently enrolling study participants. The active implementation period is 18 months.
Conclusions: This study proposes a structured, framework-informed approach to implement electronic health record–embedded
individualized pain plans with both patient and provider access in routine emergency department practice. The results of the study
will inform the implementation of electronic health record–embedded individualized pain plans at a larger scale outside of Sickle
Cell Disease Implementation Consortium centers.
Trial Registration: ClinicalTrials.gov NCT04584528; https://clinicaltrials.gov/ct2/show/NCT04584528.
International Registered Report Identifier (IRRID): DERR1-10.2196/24818
(JMIR Res Protoc 2021;10(4):e24818) doi: 10.2196/24818
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Introduction
Background
Sickle cell disease is an inherited red blood cell disorder
affecting approximately 100,000 people in the United States,
predominantly African Americans [1]. In the past few decades,
clinical interventions have facilitated significant improvement
in patient outcomes. The survival rate to adulthood in sickle
cell disease improved from less than 50% in 1970 [2] to nearly
95% in 2010 [3], and the median age at death of patients with
sickle cell disease increased from 28 years in 1979 to 43 years
in 2014 [4].
Individuals with sickle cell disease often experience acute
painful events—vaso-occlusive episodes—during which the
transfer of oxygen and nutrients to tissues is decreased because
of blood vessel blockage from polymerization [5]. These
episodes are characterized by sudden onset of excruciating pain,
often requiring high doses of opioids. Historically, pain
treatment in the emergency department for individuals with
sickle cell disease has been challenging [6]. There is a growing
demand to improve the treatment of vaso-occlusive episodes in
adults with sickle cell disease, especially in emergency
departments, where patients with sickle cell disease require
immediate pain treatment [7].
In 2014, the National Heart, Lung, and Blood Institute published
an expert panel report [8] of evidence-based recommendations
for sickle cell disease management. The use of “an
individualized prescribing and monitoring protocol or an
SCD-specific protocol whenever possible” [8] in all settings
was among the treatment recommendations for vaso-occlusive
episode treatment. For pediatric patients with sickle cell disease,
studies have found that those treated with individualized pain
plans (IPPs) had fewer hospital admissions and readmissions
as well as improved pain scores [9-11]. In these studies,
providers perceived that having an IPP improved the efficiency
and quality of pain management [9,11]. For adult patients with
sickle cell disease, however, the literature on the use of IPPs is
scarce. A randomized controlled trial has shown that adult
patients randomized to patient-specific or weight-based opioid
pain plans in the electronic health record (EHR) experienced a
significantly greater reduction in pain scores from emergency
department arrival to emergency department discharge and a
lower hospital admission rate [12]. Another retrospective study
found decreased time to first opioid and length of emergency
department stay after IPP implementation [13]. EHR use
increased from 9.4% in 2008 to 83.8% in 2015 in nonfederal
acute care hospitals [14], so these EHR-embedded individualized
pain plans are now possible in most hospitals if planned with
collaborative efforts and informed by frameworks from
Implementation Science [15].
The Sickle Cell Disease Implementation Consortium was
established in 2016 to improve the health and well-being of
adolescents and young adults with sickle cell disease [16]. The
Sickle Cell Disease Implementation Consortium is a cooperative
research program of 8 clinical centers; a data coordinating
center; and the National Heart, Lung, and Blood Institute to
promote quality of care for patients with sickle cell disease
between the ages of 15 and 45 years. Investigators in the Sickle
Cell Disease Implementation Consortium conducted a systematic
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literature review and a comprehensive needs assessment among
the 8 participating centers to identify 3 key areas of
improvement to address [17]. One of the major opportunities
for improvement was the treatment of pain in the adult
emergency department.
Patients with sickle cell disease and providers often report
frustration with emergency department care, and emergency
department providers may have negative attitudes toward
individuals living with sickle cell disease [18-21]. These factors
may result in patients having lower levels of care satisfaction
and the delay or avoidance of emergency department care
[17,21,22]. Similarly, from the Sickle Cell Disease
Implementation Consortium needs assessment, patients reported
being less pleased with their emergency department care
compared to their routine care, with only approximately half of
participants being satisfied or perceiving adequate quality care
in the emergency department [17]. Across 8 sites, 65.7% of the
437 respondents reported that they required emergency
department care for acute episodes of pain, and 34.6% of
respondents reported 3 or more hospital admissions for pain in
the previous year, which is consistent with previous reports in
the literature [17]. Slightly fewer than half of the emergency
department provider respondents reported that either their
emergency department does not have a pain treatment protocol
or they were unaware if such a protocol exists [23]. The needs
assessment results suggested that establishing standardized
treatment in adult emergency departments is key to improved
clinical outcomes and care-seeking experiences for adult patients
with sickle cell disease across 8 Sickle Cell Disease
Implementation Consortium sites. Members from the Sickle
Cell Disease Implementation Consortium formed a study
workgroup to improve emergency department care for adult
patients with sickle cell disease. The workgroup is composed
of investigators from the 8 participating Sickle Cell Disease
Implementation Consortium sites, representatives from the data




This study has 3 aims involving assessing organizational
readiness; the reach, effectiveness, adoption, implementation,
and maintenance (RE-AIM) of the electronic health
record–embedded individualized pain plans (E-IPPs); and
barriers and facilitators of E-IPP implementation and use.
Aim 1
The first aim is to assess the overall effectiveness of E-IPPs in
improving patient and provider outcomes associated with pain
treatment in the adult emergency department setting, with the
following subaims: (1) examine the effectiveness of the E-IPP
on improving patients’ perceived quality of emergency
department pain treatment and (2) examine the effectiveness of
the E-IPP on improving providers’ self-efficacy in treating pain
for patients with sickle cell disease and perceived quality of
emergency department pain treatment.
Aim 2
The second aim is to assess the reach, adoption, implementation,
and maintenance of the E-IPP components and implementation
strategies at each participating site, with the following subaims:
(1) assess the reach of the E-IPP, (2) assess the adoption and
implementation of the E-IPP and track implementation strategies
adopted by each site, and (3) assess the intent to continue using
the E-IPP from a multistakeholder perspective.
Aim 3
The third aim is to assess organizational readiness at the




The intervention for this study is E-IPPs with emergency
department provider and patient access. IPPs are records
developed by the sickle cell disease providers at each study site
based on patients’ outpatient opioid use and analgesic agent
normally required for treatment of a vaso-occlusive episode in
the emergency department (Textbox 1). Each site will work
with its local informatics team to make the E-IPPs available to
emergency department providers via the provider EHR interface
(Figure 1) and to patients via the EHR patient portal (Figure 2).
The IPPs will be reviewed by the patients’ sickle cell disease
providers every 6 months.
Sites will make adjustments to patients’ IPPs to ensure that all
participating patients have all required content and the E-IPPs
are easily accessible to emergency department providers. The
E-IPPs in the patient portal will allow patients to show their
IPPs as a credible source to any emergency department providers
in the United States.
Textbox 1. E-IPP example and content. E-IPP: electronic health record–embedded individualized pain plan.
Required individualized pain plan contents
• Genotype
• Individual pain plan—preferred analgesic agent, route, dose and dosing interval, last update time
• Name and contact information for the sickle cell disease provider
Optional individualized pain plan contents
• Allergies
• Significant past medical history specific to sickle cell disease (ie, acute chest syndrome, stroke, renal disease)
• Significant other histories relative to an emergency department visit (ie, the patient is ultrasensitive to morphine or hydromorphone)
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Figure 1. An example of an E-IPP emergency department provider interface (Washington University). E-IPP: electronic health record–embedded
individualized pain plan.
Figure 2. An example of an E-IPP patient portal (Washington University). E-IPP: electronic health record–embedded individualized pain plan.
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Study Setting
This study will take place in all 8 Sickle Cell Disease
Implementation Consortium centers (Table 1). Emergency
department practices vary. Prior to study implementation, 2
emergency departments had E-IPPs requiring additional content
insertion or building plans for some patients, while the
remainder either lacked any IPPs or only had IPPs in clinical
notes or as a hard copy in a secure server not in the EHR. One
of the sites had patient IPP access in the clinical notes before
the study, and the rest of the sites did not have patient access
to IPPs.
Table 1. Study site characteristics preimplementation.
Patient IPP
access





NoIPPs in secured servers in the emergency
department for some patients, not in the
electronic health record
AcademicUrban358AugustaAugusta University Adult Cen-
ter for Blood Disorders
NoElectronic health record–embedded IPPs,
but they do not have provider contact
AcademicSuburban450DurhamDuke University Medical Cen-
ter
NoIPPs in clinical notesAcademicUrban175New YorkMount Sinai Hospital
IPPs in clini-
cal notes
IPPs in clinical notesPrivate
hospital
Urban350MemphisMethodist University Hospital
NoNo IPPsAcademicUrban300St. LouisBarnes-Jewish Hospital
NoIPPs in clinical notesAcademicUrban286OaklandUniversity of California at San
Francisco Benioff Children’s
Hospital Oakland
NoIPPs in emergency department and clini-
cal notes for select patients
AcademicUrban600ChicagoUniversity of Illinois Hospital
& Health Sciences System,
Sickle Cell Center
NoElectronic health record–embedded IPPsAcademicUrban400CharlestonMedical University of South
Carolina Health Emergency
Department
aIPP: individualized pain plan.
Study Frameworks and Models
This study is guided by the RE-AIM framework, developed in
1999 to assess five dimensions (Reach, Effectiveness, Adoption,
Implementation, and Maintenance) [24-26]. Each dimension of
RE-AIM will be evaluated with measures at the patient,
provider, or organizational and system levels where appropriate.
RE-AIM was selected for this intervention because of its focus
on dimensions of intervention design and implementation
processes that can either facilitate or impede beneficial outcomes
and can be replicated and sustained in diverse clinical settings
[26,27].
To complement the RE-AIM framework, this study will use a
simplified version of the Technology Acceptance Model 2
(TAM2) [28] to understand E-IPP use (Figure 3). Although the
TAM2 is a comprehensive model to explain technology
acceptance and use, it includes additional constructs that are
impractical to be measured in the emergency department setting.
We have simplified the TAM2 model and will use its main
constructs to help explain the intention and actual use of the
E-IPPs.
Figure 3. Simplified Technology Acceptance Model 2.
The study protocol was also developed based on the Standard
Protocol Items for Clinical Trials [29], a guideline for the
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minimum content of a clinical trial protocol, and the Standards
for Reporting Implementation Studies [30], a guideline to
improve the reporting of implementation studies.
Study Design
The study uses a preimplementation and postimplementation
design in which the IPPs will be embedded in patient EHRs,
with both provider and patient having access to view the E-IPPs.
Multimedia Appendix 1 shows the program logic model
specifying the determinants, implementation strategies,
mechanisms of action, and outcomes [31]. The organization of
determinants is informed by the Consolidated Framework of
Implementation Research, which provides a comprehensive list
of constructs that would influence implementation [32], and the
study’s readiness assessment, described in the following section.
Figure 4 shows the study flow for each site.
Figure 4. Study flow chart. ED: emergency department; EHR: electronic health record; VOE: vaso-occlusive episode.
Given that sickle cell disease is a rare disease and most patients
with sickle cell disease do not have frequent emergency
department visits per year, the preimplementation and
postimplementation design without control groups is the most
feasible study design. Sites will overenroll participants to ensure
that enough participants will have a qualified emergency
department visit during the implementation period. Additionally,
it took a few months to 2 years for sites to work with their local
informatics teams to make the E-IPPs available to emergency
department providers and patients; therefore, a waitlist-control
or stepped-wedged design is not feasible given the study
timeline.
The study rollout will allow for emergency department provider
training of the E-IPP, development and implementation of the
E-IPPs, and evaluation postimplementation. Because of the
COVID-19 pandemic, sites have adjusted to the rollout timeline.
Two sites began the project in September 2020. The active
implementation period is 12 months from the first day of patient
enrollment, and the overall implementation phase will be 18
months.
Implementation Strategies
Based on existing evidence, workgroup expertise, and the
feasibility of implementing the E-IPP, the workgroup identified
required and optional implementation strategies at the patient
and provider levels to facilitate implementation and use of the
E-IPP (Table 2).
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Table 2. Implementation strategies at the patient and provider levels.
ProviderPatientStrategy
Required •• Provider training with a tracking logStudy orientation
•• A 5-minute video addressing stigma and the actual
prevalence of opioid addiction in sickle cell disease
[33]
Download and install electronic health record patient
portal app
• Video demonstration of how to access the E-IPPa
• Introduction to the study and demonstration of how
to access the E-IPP
• Patients will be asked to show the staff how to access
their pain plans via their phone (a teach-back method)
• Provide a wallet card with instructions to access the E-IPP
and staff contact information to take home
• Quarterly reminder text with video demonstration
Optional •• Electronic health record–embedded prompts to remind
emergency department triage clinicians of E-IPP
Communication script: provide a script at orientation for
patients to practice how to communicate with emergency
department providers about the E-IPP • Quarterly booster education sessions
• Disseminate and educate through podcasts, blogs, or jour-
nal clubs [34]
aE-IPP: electronic health record–embedded individualized pain plan.
Participants and Eligibility Criteria
Site coordinators will keep a tracking log for patient and
provider participants (Table 3).
Table 3. Eligibility criteria.
CriteriaEntity
Participating sites
Inclusion • Site hematologist or sickle cell disease provider willing to write an IPPa for patients meeting eligibility criteria
• Informatics resources available to support all aspects of the intervention
• Placement of the E-IPPb that is accessible to both the provider and patient
• Ability to support text messaging to patients for survey administration
• Support from emergency medicine and nursing leadership to agree to follow the IPP unless there is a contraindication
at the time of the emergency department vaso-occlusive episode visit
Exclusion • None
Patient participants
Inclusion • Confirmed sickle cell disease diagnosis, defined as supported by documentation in the medical record of a positive
test for 1 of the following genotypes: Hb SS, Hb SC, Hb Sβ-thalassemia, Hb SO, Hb SD, Hb SG, Hb SE, or Hb SF.
If no medical record is available, the enrolling site will conduct its own laboratory test as confirmation
• English speaking
• Age 18-45 years (National Heart, Lung, and Blood Institute grant requirement)
• Access to either an Android or iOS cellular or mobile smartphone, with access to text messaging and internet
• At least 1 vaso-occlusive episode visit to the participating site’s emergency department within the past 90 days prior
to enrollment
• At least 1 visit at the study site sickle cell disease clinic within the past 12 months
• Willing and cognitively able to give informed consent
Exclusion • Site hematologist or sickle cell disease provider states patient should not have a protocol or should not be administered
opioids
Provider participants
Inclusion • All emergency physicians, nurses, physician assistants, and nurse practitioners who work in the study emergency
department will have access to the E-IPPs as routine practice and physicians are asked to complete baseline surveys
at enrollment for research purposes
Exclusion • None
aIPP: individualized pain plan.
aE-IPP: electronic health record–embedded individualized pain plan.
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Recruitment
Patient Recruitment and Procedures
Potential participants will be approached in person, by phone,
or via electronic media about enrolling in the study. All patients
enrolled in the Sickle Cell Disease Implementation Consortium
registry and screened as eligible will be contacted by research
staff for participation in the emergency department project.
Additional participants meeting criteria at participating Sickle
Cell Disease Implementation Consortium sites not previously
enrolled in the registry are also eligible and may be recruited
in the clinic, during hospitalizations, or at community events
by research staff. Patient participants will provide informed
consent before study participation.
Provider Recruitment
All emergency department providers will be able to access the
E-IPPs and will receive training on the protocol at staff
meetings, resident conferences, or through emails. All
emergency department providers will be invited to complete a
baseline survey at enrollment with an information sheet
introducing the study. If an enrolled patient participant has a
qualified emergency department visit and the corresponding
emergency department provider has not received training or
completed the baseline survey, the study team will send a
provider follow-up survey to the provider at enrollment with
an information sheet introducing the study.
A qualified emergency department visit is defined as (1) a visit
for an enrolled patient to a participating emergency department,
the reason for the visit is a vaso-occlusive episode, and the
patient has an E-IPP at the time of the emergency department
visit; and (2) the patient’s first emergency department
vaso-occlusive episode visit of the month, after enrollment,
within the 12 month study period for that patient.
Data Collection
The data collected in this study will consist of a readiness
assessment; EHR data retrieval from patient records; patient
baseline and follow-up surveys; provider baseline and follow-up
surveys; and patient, provider, and emergency department
administrator interviews. All measures (other than the readiness
assessment) are matched with the RE-AIM framework
(Multimedia Appendix 2).
Readiness Assessment
The participating centers will administer a Readiness Diagnostic
Scale (RDS) developed by members of the Consortium’s
Implementation Research Committee at the beginning of the
implementation period [35]. The RDS is a quantitative
assessment to capture 3 interrelated dimensions of organizational
readiness: general capacities (34 items), assessing participating
emergency department’s existing emergency department practice
and how it functions overall; intervention-specific capacities
(13 items), assessing participating emergency department
capacity to use the E-IPP; and motivation (17 items), assessing
how well the emergency department facilitates physicians’
willingness to use the E-IPP.
Each site is required to have at least 5 total completed RDSs
from a study team researcher, emergency department
administrator, emergency department physician, and emergency
department nurse to capture different system-level roles in
clinical care.
EHR Data Retrieval
Each participating site will perform EHR data retrieval for
enrolled patients’ past 12 months ED visits and qualified ED
visits to collect: hospital admission rate; 7- and 30-day
emergency department revisit rate; 7- and 30-day hospital
readmission rate; time to first dose of analgesic agent; and
administered analgesic agent, dose, and route. At the end of the
project, the site will also retrieve the following from the EHR:
number of E-IPPs written and time of writing or updating,
number of new E-IPPs available in the EHR and time of
becoming available, and number of new patients at each site
who are being offered access to their pain plan in the EHR after
study enrollment targets are met. Data retrieval will follow a
manual of procedures created by the workgroup to reduce bias
[36,37].
Patient Baseline and Follow-up Survey
Each participating site will administer a brief patient baseline
survey at the time of patient enrollment that will assess patient
demographic data, patient-perceived quality of emergency
department pain treatment for the last emergency department
visit (within 90 days of enrollment), and how well the patient
knows how to use the patient portal. Within 96 hours of a
qualified emergency department visit, the research team will
send a follow-up survey by text message to the patient that will
assess patient’s perceived quality of emergency department pain
treatment for this visit, how well they know how to use the
patient portal, perceived ease of use of the E-IPP, patient and
emergency department provider use of E-IPP during the last
visit, satisfaction with the E-IPP, and intent to use the E-IPP
for next emergency department vaso-occlusive episode visit.
Patients will receive up to 3 follow-up surveys during the study
period.
Patient Interview
After a center has had 5 patients with qualified emergency
department visits, its team will begin to invite patients for
interviews within 2 weeks of a qualified emergency department
visit. The patient interview will assess the patient’s experiences
using (or not using) the E-IPP, what was helpful and challenging
about using the E-IPP, if pain treatment has changed (or not
changed) because of the E-IPP, patient satisfaction with the
E-IPP, proposed recommendations to improve the E-IPP, intent
to use the E-IPP in the future, and additional questions on
implementation strategies such as the wallet card. The research
team will use purposeful sampling for qualitative data collection
[38], based on matched patient and provider survey responses
and implementation outcomes of the IPPs.
Provider Baseline and Follow-up Survey
Each participating site will administer a brief provider baseline
survey at the time of provider enrollment that will assess
provider-perceived quality of emergency department pain
treatment and provider’s self-efficacy to manage acute pain
episodes for patients with sickle cell disease. Within 96 hours
of a qualified emergency department visit, the research team
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will send a follow-up survey via email to the enrolled provider
who ordered the first analgesic. The provider follow-up survey
will assess use of E-IPP, ease of E-IPP use, E-IPP adherence,
perceived quality of emergency department pain treatment,
satisfaction with the E-IPP, and intent to use the E-IPP in the
future.
Provider Interview
After a center has had 5 patients with qualified emergency
department visits, the team will begin to invite providers who
ordered the first analgesic for interviews within 2 weeks of a
qualified emergency department visit. The provider interview
will assess provider’s experiences using (or not using) the
E-IPPs, what was helpful and challenging about using the
E-IPPs, proposed recommendations to improve the E-IPPs,
intent to use the E-IPP in the future, and additional questions
on implementation strategies. The research team will use
purposeful sampling for qualitative data collection [38], based
on matched patient and provider survey responses and
implementation outcomes of the E-IPPs.
Emergency Department Administrator Interview
At the end of the implementation period, each site team will
invite emergency department administrators to a
postimplementation interview that will assess barriers and
facilitators to intervention implementation, emergency
department administrator’s experiences implementing and using
the E-IPP, and emergency department administrator’s intent to
continue using the E-IPP in the future.
Tracking and Reporting Implementation Strategies
A parallel study has been funded to capture the planned and
actual implementation strategies employed by each site [39].
Semistructured interviews with 3 stakeholders from each site
before participant recruitment and at the end of the intervention,
as well as quantitative surveys at the midpoint of project
implementation, will capture the barriers and facilitators of the
strategies planned and whether there have been any adaptations
made. Questions have been informed by the implementation
and maintenance domains of the RE-AIM framework.
Statistical Analysis Power and Sample Size
The study plans to have an analytical sample size of 160 patient
participants, 20 for each site, for its primary outcome analysis.
Each site is expected to enroll approximately 40 participants to
reach the analytical sample size.
Sample size was calculated for the primary outcome, patient
satisfaction with emergency department pain treatment through
their perceived quality of emergency department pain treatment.
For the power calculations, we used results from the Sickle Cell
Disease Implementation Consortium needs assessment [17, 23],
which used similar measurements to assess patient satisfaction
with emergency department pain treatment. We assumed that
the correlations between responses would not change and
conducted a simulation to determine statistical power to detect
a treatment difference of half a standard deviation. The sample
estimation model has several assumptions: the intervention
effect will vary across sites with the standard deviation for the
random intervention effect set at 0.447; within-site correlation
(commonly referred to as intercluster correlation) of baseline
measurements, calculated as the ratio of site-level variance over
the total variance, is set at 0.10; and within-participant
correlation, calculated as the ratio of individual-level variance
over total individual variance, is set at 0.50, reflecting the
expectation that the preintervention composite score is predictive
of the postintervention score.
Based on the Sickle Cell Disease Implementation Consortium
registry data, we estimated that at least 50% of the study patient
participants will have at least 1 qualified emergency department
visit during the study period and that approximately 20% of the
participants will be lost to follow-up and provide no posttest
data. The total number of patients a site will recruit is
approximately 40. The results indicate that the study will have
>90% power to reject the null hypothesis when the intervention
results in an average improvement in patient-perceived quality




The primary outcome is patient satisfaction with emergency
department pain treatment through their perceived quality of
emergency department pain treatment (Multimedia Appendix
2). This is measured with a composite of 3 questions developed
based on the Adult Sickle Cell Quality of Life Measure Quality
of Care measure [6]. The impact of the intervention on the
primary outcome will be estimated using a linear mixed model.
A 3-level model with random effects for site, participants nested
within site, and site-to-site variation in the treatment effect and
a fixed effect for treatment response will be specified to assess
the impact of the intervention. The primary analysis will be
based on the preintervention composite score and the score at
1 emergency department visit per participant, using the first
visit for those with more than one. The model can accommodate
multiple visits per participant by adding a covariance matrix to
account for repeated observations.
Other Outcomes
The secondary outcomes of hospital admission rate (a count
outcome, as multiple hospital admissions are possible), 7-day
emergency department vaso-occlusive episode revisit (a
dichotomous outcome), and time to first dose, and other
provider-level outcomes will be analyzed with generalized linear
mixed models, where the outcome will be specified as a Poisson
or binomial variable with a logit function as needed by the data
type of outcome. The generalized linear mixed models would
follow the same format as the linear mixed model with fixed
effects for time, intervention, and covariates and random effects
for participants within sites. The secondary outcome of
satisfaction with IPP, measured with a single Likert scale
question for both patient and provider, will be analyzed as a
continuous outcome with a linear mixed model as detailed above
for the primary outcome. In all cases, the analysis will estimate
an intervention effect that will compare the secondary outcome
at baseline to after the intervention is delivered. Power
calculations indicate that the study sample will be too small to
detect statistically significant differences in these noncontiguous
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variables, but estimates will be provided to inform future
research.
The analysis of the quantitative readiness assessment result and
the reach, adoption, implementation, and maintenance outcomes
will be descriptive. As a preliminary attempt, at the end of the
intervention, the results of the readiness assessment will inform
our interpretation of the implementation and effectiveness
outcomes. Sites with a lower level of readiness may face
challenges during implementation, which will affect their
implementation outcome and intervention effectiveness.
For qualitative interviews, the workgroup members will develop
a codebook informed by the RE-AIM framework for data
analysis. Using a deductive approach, the codebook will include
an initial list of codes to be used in the analysis and definitions
or operationalized examples for each code. Analysts will revise
the codebook as necessary to hone definitions to increase
consistency in coding across the research teams. Data will be
compiled into different stakeholder groups by themes and
analyzed across the study sites.
Results
At the time of submission, this study was approved by the
institutional review board of Duke University (IRB Pro
000073506), Icahn School of Medicine at Mount Sinai (IRB
20-04302), Medical University of South Carolina (IRB Pro
00097830), Washington University School of Medicine (IRB
202006209), University of California San Francisco (IRB
20-30981), University of Illinois Chicago (IRB 2016-02998).
The full protocol and study manual of procedures are available
from the corresponding author upon request. The study is
registered (NCT04584528) and enrolling participants. Sites that
did not have IPPs for all patients are working with the sickle
cell disease providers to build the plans with patients during
clinic visits. Because of the COVID-19 outbreak, sites have
changed the planned recruitment timeline and will continue
enrolling until the target is reached.
Discussion
With the rapid expansion of the use of EHR in the past decade,
building an EHR-embedded treatment plan for different patient
populations has gained increased interest, especially in the
emergency department, where decision making is time sensitive.
Previous research has explored various decision support tools,
including treatment plans, to facilitate emergency department
provider decision making [11,40-42]. The E-IPP intervention
is a direct result of a large-scale needs assessment effort and is
designed to meet the needs of participating sites and patient
populations. Guided by the RE-AIM theoretical framework and
a widely used TAM2 model explaining technology uptake, the
protocol proposes to test the effectiveness of the E-IPP while
also describing how the intervention is implemented and
assessing implementation outcomes in detail.
Previous research on individualized treatment plans for patients
with sickle cell disease has largely been conducted in pediatric
settings [9-11]. These studies demonstrated that providers
perceived that digitization of the treatment plans could help
improve the efficiency and quality of pain management [9-11].
So far, only 1 randomized controlled trial [12] has tested the
effectiveness of an individualized treatment plan compared to
a weight-based plan for adult patients with sickle cell disease
and showed significant efficacy, but the results were not
generalizable, as it was conducted in only 2 emergency
departments with 52 patients. While previous studies have
focused on assessing patient outcomes, this study will assess
multilevel outcomes, including patient experience and
satisfaction. With a comprehensive understanding of the uptake
and implementation of the E-IPPs, the intervention will be more
likely to successfully be disseminated to other emergency
departments on a large scale.
The most novel component of this protocol is making the E-IPP
available to the patient. Many sickle cell centers already make
IPPs available to the emergency department provider, but few
have been able to make these accessible to the patient. Among
8 Sickle Cell Disease Implementation Consortium sites, only 1
site had patient IPP access through the clinical notes. With this
project, patients will have easy E-IPP access and will be able
to present their IPPs to the emergency department provider
directly via the patient portal app on their cellular device. In the
past decade, smartphone ownership has increased significantly
in the United States, even among low- and moderate-income
communities [43]. Over 70% of individuals with an annual
income of less than $30,000 reported smartphone ownership in
2019, and the rates of smartphone ownership among patients
with sickle cell disease are similar [43-45]. Previous studies
[46-48] have identified barriers to patients accessing and using
an EHR, and participants with limited health literacy may need
additional time to navigate the EHR patient portal. Previous
literature has demonstrated substantial disparities in portal use,
indicating that vulnerable populations, such as racial and ethnic
minorities and individuals with low socioeconomic status, are
less likely to use patient portals, which is relevant for sickle cell
disease, as the majority of individuals living with sickle cell
disease are African American [49,50]. This study will
accommodate many barriers by providing a one-on-one session
to help patients install the patient portal for E-IPP access and
by providing a wallet card with instructions and videos of how
to access their E-IPPs. As previous exploratory research on
disease-specific patient portals in patients with sickle cell disease
has achieved high acceptability, the E-IPPs, within a few clicks
from the main menu, are likely to be viewed favorably by study
participants [50]. The study will be able to explore whether
patient access to E-IPPs will help with their treatment
experiences in the emergency departments.
For the protocol, a significant challenge is to balance the desire
for robust study design with practical needs in the emergency
departments, which is common for implementation research
studies [51]. Acknowledging that a preimplementation and
postimplementation study design without control groups has
limitations, it is the only feasible solution given that sickle cell
disease is a rare disease and study sites must overenroll
participants to collect data on enough emergency department
visits to generate meaningful results. All emergency department
sites want to adopt E-IPP implementation to improve practice
as soon as possible. The protocol uses comprehensive mixed
Luo et alJMIR RESEARCH PROTOCOLS
methods data collection [52] to compensate for the study design
to achieve the 3 study aims. Some of the activities will be
exploratory in nature and provide preliminary data to inform
future work expanding the E-IPP on a larger scale and beyond
academic settings.
Another significant challenge is that the Sickle Cell Disease
Implementation Consortium consists of 8 academic sites, and
local practices vary. Because the EHR systems may be
structured in different ways, sites have spent an extensive
amount of time working with their local informatics teams to
make the E-IPPs available in both patient and provider channels.
The protocol has adopted several measures to capture and
address this diversity, including surveying sites about their
existing practices, incorporating the readiness assessment
component to help sites understand capacity and motivations
that may be unique to their site, and a separate protocol to solely
focus on implementation strategies and adaptations at the site
level.
In summary, this study proposes a framework-informed,
structured approach to implement a guideline recommendation
in routine emergency department practice. It is the first multisite
study investigating the effectiveness of E-IPPs in adult
emergency departments at both the provider and patient levels.
The results of the study will inform the implementation of IPPs
with emergency department provider and patient access at a
larger scale.
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